Insights On Outsourced Drug Development

  1. UPLC-MS/MS Determination Of GLP-1 Analogue 7/17/2025

    Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.

  2. Production And Purification Of AAV At The 50 L Scale 12/4/2023

    Explore data demonstrating the performance of a scalable system for AAV manufacturing that enables gene therapy researchers to utilize a single system throughout the entire development process.

  3. Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration 8/20/2025

    Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.

  4. Advantages Of Spray-Dried Mannitol In Roll Compaction 4/2/2025

    Pharmaceutical excipients like mannitol enhance formulation stability, flowability, and compressibility, which are crucial for robust tablets. Read how these properties improve patient compliance.

  5. Benefits Of Working With A Custom Media Development Collaborator 9/13/2023

    Choosing a custom cell culture media formulation can improve your biopharma manufacturing process performance, and working with media development collaborators can help you navigate that process.

  6. Don't Skip Preformulation: Your Blueprint For Drug Development Success 9/22/2023

    Investing in the right preformulation studies and gathering evidence to inform decisions is critical to identify product dead-ends and failure modes without the pain of hindsight.

  7. Together, Let's Sail Toward Success 7/23/2025

    Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.

  8. Thermal Analysis In The Pharmaceutical Industry 12/30/2024

    Thermal analysis techniques provide valuable insights into pharmaceutical material properties, ensuring compatibility, stability, and quality control in drug development and production processes.

  9. Robust, Scalable Strategy For Monodisperse Nanosuspensions Of Poorly Soluble Drugs 5/16/2025

    By tailoring the formulation strategy, selecting the appropriate excipients, and fine-tuning process conditions, see how our team was able to improve bioavailability and in vivo exposure.

  10. How To Accelerate And Enhance ADC Therapies 6/24/2024

    Learn how payloads and advanced payload intermediates can expedite drug development and elevate ADC therapies, and explore ADC payloads, payload intermediates, and solubility-enhancing technology.